- Home
- JAGX vs ATNF Comparison
JAGX vs ATNF Comparison
Compare JAGX & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- ATNF
- Stock Information
- Founded
- JAGX 2013
- ATNF 2016
- Country
- JAGX United States
- ATNF United States
- Employees
- JAGX N/A
- ATNF N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- JAGX Health Care
- ATNF Health Care
- Exchange
- JAGX Nasdaq
- ATNF Nasdaq
- Market Cap
- JAGX 3.5M
- ATNF 3.8M
- IPO Year
- JAGX N/A
- ATNF N/A
- Fundamental
- Price
- JAGX $2.58
- ATNF $0.83
- Analyst Decision
- JAGX Strong Buy
- ATNF
- Analyst Count
- JAGX 1
- ATNF 0
- Target Price
- JAGX $60.00
- ATNF N/A
- AVG Volume (30 Days)
- JAGX 90.6K
- ATNF 35.4K
- Earning Date
- JAGX 08-12-2025
- ATNF 08-11-2025
- Dividend Yield
- JAGX N/A
- ATNF N/A
- EPS Growth
- JAGX N/A
- ATNF N/A
- EPS
- JAGX N/A
- ATNF N/A
- Revenue
- JAGX $11,552,000.00
- ATNF N/A
- Revenue This Year
- JAGX $22.41
- ATNF N/A
- Revenue Next Year
- JAGX $30.00
- ATNF N/A
- P/E Ratio
- JAGX N/A
- ATNF N/A
- Revenue Growth
- JAGX 13.93
- ATNF N/A
- 52 Week Low
- JAGX $2.43
- ATNF $0.66
- 52 Week High
- JAGX $110.75
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- JAGX 28.76
- ATNF 35.60
- Support Level
- JAGX $2.61
- ATNF $0.95
- Resistance Level
- JAGX $3.30
- ATNF $1.04
- Average True Range (ATR)
- JAGX 0.28
- ATNF 0.08
- MACD
- JAGX 0.06
- ATNF -0.01
- Stochastic Oscillator
- JAGX 6.56
- ATNF 17.41
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.